Navigation Links
PharmScript Offers Insight on Updates to F309 – Quality of Care
Date:8/30/2013

Edison, NJ (PRWEB) August 30, 2013

PharmScript reminds long-term care facilities that the Centers for Medicare and Medicaid Services (CMS) recently implemented new F309 Quality of Care Guidance to surveyors for determining nursing facility compliance with end of life care requirements.

New guidelines specify that medical treatments should be assessed by the health care team, weighing potential benefits against potential burdens or risks for residents. The consultant pharmacist is an important resource in these efforts and in documenting medication-related decisions.

Palliative care as an option provides individualized comfort measures, even if the resident does not choose the involvement of hospice. According to CMS, decisions about diagnostic tests, medical procedures, and medication use should include consideration of the individual’s prognosis, choices, personal values, desired level of comfort, and dignity.

The consultant pharmacist brings valuable knowledge to the discussion to ensure that medication use is consistent with the goals of comfort, symptom control, and supporting the level of alertness desired by the individual.

"Symptom relief is a key component in assuring comfort and supporting death with dignity," said Saul Greenberger, founder of East Coast-based long-term care pharmacy PharmScript. "Pharmacy's expertise is beneficial as adjustments are made to attain desired pain relief while managing an individual’s side effects."

The new F309 guidance also includes the following recommended ABCDE Mnemonic for use in meeting an individual’s needs at the end of life:

A.    Ask about and screen for pain and other symptoms related to the resident’s end of life status on admission and periodically thereafter. Assess regularly for symptoms and their impact on the resident.

B.    Believe the resident’s report of pain or other symptoms, what precipitates it or makes it worse, and what relieves it.

C.    Choose symptom control options that are appropriate for the individual.

D.    Deliver interventions in a timely, logical, coordinated manner.

E.    Empower the resident to participate in creating treatment goals and planning interventions as possible. Evaluate the effectiveness of the chosen interventions.

Your consultant pharmacist, working with the physician and the nursing team, can make recommendations designed to guide medication management, symptom relief, and side-effect reduction. Invite him or her to work with you as you develop protocols with a range of comfort measures for your residents with end of life needs.

To read more helpful tips on how to maximize the pharmacy experience, visit PharmScript’s learning center at http://www.pharmscript.com/learning.html.

About PharmScript:
The unique principles upon which PharmScript was founded were based on years of invaluable experience in the long-term care industry. Comprised of a reputable and experienced management team, PharmScript is geared toward providing the ultimate pharmacy experience utilizing cutting-edge technology, impeccable customer service, and assisting facilities in saving on pharmacy costs. Pharmscript currently services New York, New Jersey, Pennsylvania, Delaware, Washington DC, Maryland, Florida and Texas.

Read the full story at http://www.prweb.com/releases/F309/pharmscript/prweb11078830.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PharmScript on Pain Management in Nursing Communities: Consult a Pharmacist
2. Spirituality and Practice Offers Innovative New Way to Support the Spiritually Independent
3. Net Worth Commerce TV Offers a Segment on Planning for Retirement
4. Fertility Practice Offers Acupuncture in Trumbull Reproductive Medicine Associates of CT Hires Elaine M. Malin, MTCM, L.Ac. to Work with Fertility Patients
5. The Orthopaedic and Spine Institute Offers a Football Accident and Recovery Program for Athletes
6. OxySleep Discount Offers: Naturalherbalz.net Now Offers Extra 3 Month Supply on Purchase of 3 Month Package
7. Spectrum Surgical Offers Basic Prophylaxis Veterinary Dental Kit
8. Diet Doc Prescription Diets & Weight Loss Plans Now Offers Unlimited Clinical Support for Each Patient’s Weight Loss Journey
9. Hospice Savannah Offers 2014 Pet Calendar
10. Lilysilk.com Offers Three Tips On How To Choose A Silk Pillow
11. TheHardwareCity.com Offers A Specialty Aquarium Toilet Seat Manufactured by Jones Stephens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: